| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.08 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.08 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.09 |